Desbutal

From WikiMD's Medical Encyclopedia

Revision as of 14:01, 10 February 2025 by Prab (talk | contribs) (CSV import)

Desbutal was a combination drug composed of two active ingredients: methamphetamine and pentobarbital. It was used primarily in the mid-20th century for its stimulant and sedative effects. The drug was prescribed for various conditions, including depression, anxiety, and narcolepsy.

Composition and Mechanism of Action

Desbutal combined the stimulant properties of methamphetamine with the sedative effects of pentobarbital. Methamphetamine is a potent central nervous system (CNS) stimulant that increases the release of neurotransmitters such as dopamine and norepinephrine, leading to increased alertness, concentration, and energy. Pentobarbital, on the other hand, is a barbiturate that acts as a CNS depressant, producing sedative and hypnotic effects by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA).

Medical Uses

Desbutal was prescribed for a variety of conditions:

  • Depression: The stimulant component helped alleviate symptoms of depression by increasing energy and mood.
  • Anxiety: The sedative component helped reduce anxiety and promote relaxation.
  • Narcolepsy: The stimulant component helped manage excessive daytime sleepiness and sudden sleep attacks.

Side Effects and Risks

The combination of a stimulant and a sedative in Desbutal posed significant risks, including:

  • Addiction: Both methamphetamine and pentobarbital have high potential for abuse and dependence.
  • Cardiovascular issues: The stimulant effects of methamphetamine could lead to increased heart rate and blood pressure.
  • Respiratory depression: The sedative effects of pentobarbital could cause respiratory depression, especially in high doses.

Regulation and Discontinuation

Due to the high potential for abuse and the availability of safer alternatives, Desbutal was eventually discontinued. The Controlled Substances Act and other regulatory measures led to stricter controls on the prescription and distribution of both methamphetamine and pentobarbital.

Related Pages

This article is a stub related to pharmacology. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.